KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Total Debt (2019 - 2025)

Historic Total Debt for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Q3 2025 value amounting to $59.7 million.

  • Rigel Pharmaceuticals' Total Debt fell 5.35% to $59.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year decrease of 5.35%. This contributed to the annual value of $59.7 million for FY2024, which is 13.09% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Total Debt stood at $59.7 million, which was down 5.35% from $59.8 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Total Debt registered a high of $59.8 million during Q2 2025, and its lowest value of $19.8 million during Q1 2021.
  • For the 5-year period, Rigel Pharmaceuticals' Total Debt averaged around $46.0 million, with its median value being $59.6 million (2023).
  • Its Total Debt has fluctuated over the past 5 years, first soared by 10189.24% in 2021, then fell by 5.35% in 2025.
  • Rigel Pharmaceuticals' Total Debt (Quarter) stood at $19.9 million in 2021, then surged by 98.09% to $39.4 million in 2022, then soared by 51.09% to $59.6 million in 2023, then increased by 0.13% to $59.7 million in 2024, then increased by 0.08% to $59.7 million in 2025.
  • Its Total Debt was $59.7 million in Q3 2025, compared to $59.8 million in Q2 2025 and $59.7 million in Q1 2025.